Clinical Trial Update: Glucagon-Like Peptide 1 Receptor Agonist in Diabetes Mellitus Management in Children and Adolescents With Transfusion-Dependent Thalassemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a glucagon-like peptide-1 receptor agonist for diabetes management in children and adolescents with transfusion-dependent be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Transfusion-dependent Beta-thalassemia

Drugs mentioned

• GLP-1 receptor agonist

Snippet

Sponsor: Ain Shams University | Conditions: Transfusion Dependent Beta Thalassemia | Phase 2 | Status: COMPLETED